Federal update: DOJ partially rescheduled medical cannabis to Schedule III (April 28, 2026 final order). State-licensed medical operators may apply for expedited DEA registration through June 27, 2026; DEA hearing on full rescheduling set for June 29, 2026.
Industry & Commerce ⚠️ Disputed

Social equity license

⚠️ Disputed term. A social equity license is a cannabis business license issued under state or municipal programs providing preferences — application fee waivers, scoring points, dedicated license tranches, grants, loans, and technical assistance — to individuals and communities disproportionately harmed by cannabis prohibition. Eligibility is typically defined by past cannabis convictions (self or family), residence in "disproportionately impacted areas," or income thresholds. Major programs include Massachusetts (2016), Illinois (CRTA 2019), New York's CAURD program (MRTA 2021), New Jersey (CREAMM 2021), California (SB 1294, 2018), and Michigan, Missouri, Maryland, Arizona, Connecticut, and Virginia. Outcomes have been widely criticized: predatory financing and license flipping, single corporate sponsors backing dozens of "equity" applicants (Illinois Well-Being litigation), unworkable capital structures (NY CAURD licensees reported buildout costs exceeding projections by 2x+), and Dormant Commerce Clause vulnerability on residency preferences (NPG v. Maine, 1st Cir.). MJBizDaily reporting in 2023 found fewer than 20 of ~10,000 U.S. dispensaries were Black-owned. Defenders — including the Minority Cannabis Business Association — argue programs need more funding, automatic expungement, and community reinvestment rather than abandonment. Governor Hochul publicly called New York's CAURD rollout "a disaster." → See also: License, Microbusiness, Dormant Commerce Clause (Part 6)